Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 11/2005

01-11-2005

Relevance of Adjusted Cut-off Values in Commercial Serological Immunoassays for Helicobacter pylori Infection in Children

Authors: Paul Harris, MD, Guillermo Perez-Perez, PhD, Alejandro Zylberberg, MD, Antonio Rollán, MD, Carolina Serrano, MSc, Francisca Riera, MSc, Helly Einisman, MSc, Daniela García, MSc, Paola Viviani, MPH

Published in: Digestive Diseases and Sciences | Issue 11/2005

Login to get access
Metadata
Title
Relevance of Adjusted Cut-off Values in Commercial Serological Immunoassays for Helicobacter pylori Infection in Children
Authors
Paul Harris, MD
Guillermo Perez-Perez, PhD
Alejandro Zylberberg, MD
Antonio Rollán, MD
Carolina Serrano, MSc
Francisca Riera, MSc
Helly Einisman, MSc
Daniela García, MSc
Paola Viviani, MPH
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 11/2005
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-3015-9

Other articles of this Issue 11/2005

Digestive Diseases and Sciences 11/2005 Go to the issue

OriginalPaper

A Prospective Study of Gastric Acid Analysis and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Refractory to Medical Therapy

OriginalPaper

Inverse Dose Effect of Pretest Dietary Lactose Intake on Breath Hydrogen Results and Symptoms in Lactase Nonpersistent Subjects

OriginalPaper

Gender Differences in Pain and Biomechanical Responses After Acid Sensitization of the Human Esophagus

OriginalPaper

Determination of Plasma Trypsin-Like Activity in Healthy Subjects, Patients With Mild to Moderate Alcoholic Chronic Pancreatitis, and Patients With Nonjaundice Pancreatic Cancer

OriginalPaper

Temperature and Vascular Volume Effects on Gastric Ulcerogenesis After Cord Transection

OriginalPaper

Gastric Mucosal Protection via Enhancement of MUC5AC and MUC6 by Geranylgeranylacetone
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits